跳至主要内容
临床试验/NCT03796104
NCT03796104招募中不适用

Prognostic Impact of Delta-haemolysin Production Deficiency in Staphylococcus Aureus on the Prognosis of Infected Implant Treated by DAIR

Hospices Civils de Lyon1 个研究点 分布在 1 个国家目标入组 100 人开始时间: 2018年1月1日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
100
试验地点
1
主要终点
Rate of infection with or witout delta-haemolysin in Staphylococcus Aureus

研究概览

简要总结

The aim of this study is to determine if delta-haemolysin production deficiency of Staphylococcus aureus is a marker in favour of chronic infections on implants

研究设计

研究类型
Observational
观察模型
Case Control
时间视角
Prospective

入排标准

年龄范围
18 Years 至 99 Years(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • patients having implant infection due to S. aureus treated by DAIR

排除标准

  • 未提供

结局指标

主要结局

Rate of infection with or witout delta-haemolysin in Staphylococcus Aureus

时间窗: Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption

patients, profile of the bacterium, medical and chirurgical treatment, rate. comparison between the 2 groups

次要结局

  • Rate of Treatment Failure(Outcome is measured at the end of follow-up (usually between 12 and 24 months after antibiotic therapy disruption)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Eugénie MABRUT

clinical research assistant

Hospices Civils de Lyon

研究点 (1)

Loading locations...

相似试验